Not logged in Share Save
Share Save
Share Save
Pembrolizumab with platinum-based chemotherapy with or without epacadostat as first-line treatment for metastatic non-small cell lung cancer: a randomized, partially double-blind, placebo-controlled phase II study Boyer, Michael; Hui, Rina; Urban, Damien; Clingan, Philip; Su, Wu-Chou; Devaux, Celine; Gadgeel, Shirish; Garassino, Marina; Leopold, Lance; Daniel, Jeannie; Munteanu, Mihaela C.; Samkari, Ayman; Luo, Yiwen; Abreu, Delvys Rodriguez Share Save
Avelumab in Combination With Lorlatinib or Crizotinib in Patients With Previously Treated Advanced NSCLC: Phase 1b/2 Results From the JAVELIN Lung 101 Trial Solomon, Benjamin J.; Dagogo-Jack, Ibiayi; Lee, Se-Hoon; Boyer, Michael J.; Ramalingam, Suresh S.; Carcereny, Enric; Felip, Enriqueta; Han, Ji-Youn; Hida, Toyoaki; Hughes, Brett G. M.; Kim, Sang -We; Nishio, Makoto; Seto, Takashi; Okamoto, Tatsuro; Zhang, Xiaoxi; Martini, Jean -Francois; Wang, Erjian; De Beukelaer, Steven; Bauer, Todd M. Share Save
Chimeric antigen receptor macrophages ( MOTO CARs) driving repolarization of macrophages in solid tumors Boyer, Michael; Townsend, Michelle; Phares, Timothy; Blaszczak, Adam; Garlick, Rachel; Katschke, Kenneth; Shrestha, Gaju; Mortimer, Toni; Cowager, Ashlin; Jensen, McCall; Cheever, Abigail; O'Neill, Kim Share Save
Real world efficacy and toxicity of consolidation durvalumab following chemoradiotherapy in older Australian patients with unresectable stage III non-small cell lung cancer Stevens, Samuel; Nindra, Udit; Shahnam, Adel; Wei, Joe; Bray, Victoria; Pal, Abhijit; Yip, Po Yee; Linton, Anthony; Blinman, Prunella; Nagrial, Adnan; Lee, Jenny; Boyer, Michael; Kao, Steven Share Save
First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry study Brown, Lauren Julia; Khou, Victor; Brown, Chris; Alexander, Marliese; Jayamanne, Dasantha; Wei, Joe; Gray, Lauren; Chan, Wei Yen; Smith, Samuel; Harden, Susan; Mersiades, Antony; Warburton, Lydia; Itchins, Malinda; Lee, Jenny H.; Pavlakis, Nick; Clarke, Stephen J.; Boyer, Michael; Nagrial, Adnan; Hau, Eric; da Silva, Ines Pires; Kao, Steven; Kong, Benjamin Y. Share Save
Share Save
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions Zhou, Caicun; Tang, Ke-Jing; Cho, Byoung Chul; Liu, Baogang; Paz-Ares, Luis; Cheng, Susanna; Kitazono, Satoru; Thiagarajan, Muthukkumaran; Goldman, Jonathan W.; Sabari, Joshua K.; Sanborn, Rachel E.; Mansfield, Aaron S.; Hung, Jen-Yu; Boyer, Michael; Popat, Sanjay; Mourao Dias, Josiane; Felip, Enriqueta; Majem, Margarita; Gumus, Mahmut; Kim, Sang-we; Ono, Akira; Xie, John; Bhattacharya, Archan; Agrawal, Trishala; Shreeve, S. Martin; Knoblauch, Roland E.; Park, Keunchil; Girard, Nicolas; PAPILLON Investigators Share Save
Amivantamab plus chemotherapy vs chemotherapy as a first-line treatment among Asian patients with EGFR exon 20 insertion-mutated advanced non-small cell lung cancer (NSCLC): PAPILLON subgroup analysis Zhou, C.; Tang, K.; Liu, B.; Kim, S-W.; Kitazono, S.; Ono, A.; Thiagarajan, M.; Hung, J-Y.; Boyer, M.; Xie, J.; Bhattacharya, A.; Baig, M.; Agrawal, T.; Knoblauch, R. E.; Cho, B. C. Share Save
Genetic or therapeutic neutralization of ALK1 reduces LDL transcytosis and atherosclerosis in mice Lee, Sungwoon; Schleer, Hubertus; Park, Hyojin; Jang, Erika; Boyer, Michael; Tao, Bo; Gamez-Mendez, Ana; Singh, Abhishek; Folta-Stogniew, Ewa; Zhang, Xinbo; Qin, Lingfeng; Xiao, Xue; Xu, Lin; Zhang, Junhui; Hu, Xiaoyue; Pashos, Evanthia; Tellides, George; Shaul, Philip W.; Lee, Warren L.; Fernandez-Hernando, Carlos; Eichmann, Anne; Sessa, William C. Share Save
An Australian aged care home for people subject to homelessness: health, wellbeing and cost-benefit O'Connor, Claire M. C.; Poulos, Roslyn G.; Sharma, Anurag; Preti, Costanza; Reynolds, Najwa L.; Rowlands, Allison C.; Flakelar, Kyall; Raguz, Angela; Valpiani, Peter; Faux, Steven G.; Boyer, Michael; Close, Jacqueline C. T.; Gupta, Leena; Poulos, Christopher J. Share Save
Share Save
Share Save
Share Save
Share Save
Pembrolizumab plus ipilimumab or placebo in previously untreated metastatic NSCLC with PD-L1 tumor proportion score ≥50%: KEYNOTE-598 3-year follow-up Abreu, D. Rodriguez; Reck, M.; Sendur, N.; Park, K.; Lee, D. H.; Cicin, I.; Yumuk, P. F.; Orlandi, F. J.; Leal, T. A.; Soparattanapaisarn, N.; Langleben, A.; Califano, R.; Medgyasszay, B.; Hsia, T-C.; Otterson, G. A.; Woods, T.; Jensen, E.; Samkari, A.; Boyer, M. Share Save
Oral Squamous Cell Carcinoma in Young Patients Show Higher Rates of EGFR Amplification: Implications for Novel Personalized Therapy Satgunaseelan, Laveniya; Porazinski, Sean; Strbenac, Dario; Istadi, Aji; Willet, Cali; Chew, Tracy; Sadsad, Rosemarie; Palme, Carsten E.; Lee, Jenny H.; Boyer, Michael; Yang, Jean Y. H.; Clark, Jonathan R.; Pajic, Marina; Gupta, Ruta Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
